Business Plan for 2013
At its session held on December 28th 2012, the Managing Board of Alkaloid AD Skopje adopted the business plan of the company for 2013. The Business Plan is based on the following:
- realistic expectations, projections and opportunities of the current and new markets and products;
- risk management policies;
- increasing the efficiency of company resources.
The business plan anticipates continuous investments in human resources, investment of around 8.5% of the consolidated sales in tangible and intangible assets from own sources, a growth in consolidated sales of at least 6% compared to the expected for 2012, as well as a growth in pre-tax consolidated profit of at least 5% in comparison with the expected for 2012.
It is expected that the domestic market will account for 40.8% of the consolidated sales, whereas 59.2% will come from exports.
The breakdown by Profit Centres anticipates that the PC Pharmaceuticals will account for 83.6% of the consolidated sales, while PC Chemistry, Cosmetics and Botanicals 16.4%.